Page last updated: 2024-09-03

galactosyl-(1-3)galactose and Colorectal Cancer

galactosyl-(1-3)galactose has been researched along with Colorectal Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chera, B; Deal, AM; Gilbert, J; Grilley Olson, J; Hayes, DN; Murphy, BA; Weiss, J; Weissler, M	1

Trials

1 trial(s) available for galactosyl-(1-3)galactose and Colorectal Cancer

Article	Year
Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab. Cancer, 2016, 06-01, Volume: 122, Issue:11 Topics: Albumins; Anaphylaxis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Colorectal Neoplasms; Disaccharides; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Immunoglobulin E; Paclitaxel; Predictive Value of Tests; Prospective Studies; Smoking; Southeastern United States	2016

Article

Year

Using the galactose-α-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.

Cancer, 2016, 06-01, Volume: 122, Issue:11

Topics: Albumins; Anaphylaxis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cetuximab; Colorectal Neoplasms; Disaccharides; Enzyme-Linked Immunosorbent Assay; Head and Neck Neoplasms; Humans; Immunoglobulin E; Paclitaxel; Predictive Value of Tests; Prospective Studies; Smoking; Southeastern United States

2016